KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Fulgent Genetics (FLGT) over the last 7 years, with Q3 2025 value amounting to $6.9 million.

  • Fulgent Genetics' Other Accumulated Expenses rose 7011.32% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 7011.32%. This contributed to the annual value of $4.7 million for FY2024, which is 1233.69% up from last year.
  • Fulgent Genetics' Other Accumulated Expenses amounted to $6.9 million in Q3 2025, which was up 7011.32% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Other Accumulated Expenses registered a high of $39.9 million during Q3 2021, and its lowest value of $281000.0 during Q3 2023.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $4.2 million (2023), whereas its average is $6.7 million.
  • In the last 5 years, Fulgent Genetics' Other Accumulated Expenses crashed by 9793.7% in 2023 and then soared by 134555.16% in 2024.
  • Fulgent Genetics' Other Accumulated Expenses (Quarter) stood at $680000.0 in 2021, then surged by 679.56% to $5.3 million in 2022, then decreased by 20.49% to $4.2 million in 2023, then rose by 12.34% to $4.7 million in 2024, then soared by 45.93% to $6.9 million in 2025.
  • Its Other Accumulated Expenses was $6.9 million in Q3 2025, compared to $5.0 million in Q2 2025 and $4.3 million in Q1 2025.